Table 4 Changes in body composition between diagnosis and recurrence
| Â | Whole cohort | Initial high SMI group | Initial low SMI group | Â | |||||
|---|---|---|---|---|---|---|---|---|---|
| Â | At diagnosis | At relapse | P-value* | At diagnosis | At relapse | P-value* | At diagnosis | At relapse | P-valuea |
SMI (cm2/m2), median (range) | 44.9 (25.3–75.2) | 45.4 (30.8–78.2) | 0.08 | 58.0 (42.6–75.2) | 55.2 (39.4–78.2) | < 0.001 | 42.3 (25.3–51.8) | 44.5 (30.8–52.3) | 0.71 |
VAT index (cm2/m2), median (range) | 52.2 (1.4–164.4) | 58.6 (3.7–160.7) | < 0.001 | 68.9 (6.9–159.8) | 72.0 (16.4–95.6) | 0.014 | 43.7 (1.4–164.4) | 56.7 (3.7–160.7) | 0.82 |
SAT index (cm2/m2), median (range) | 44.5 (0.6–61.8) | 43.7 (5.09–198.4) | 0.8 | 23.6 (2.4–55.3) | 71.1 (21.2–198.4) | 0.77 | 15.6 (0.6–61.8) | 42.7 (5.09–101.9) | 0.54 |
IMAT index (cm2/m2), median (range) | 0.12 (0.0–0.5) | 0.09 (0.02–0.5) | 0.9 | 0.09 (0.1–0.5) | 0.09 (0.02–0.5) | 0.60 | 0.11 (0.0–0.5) | 0.10 (0.02–0.4) | 0.74 |
BMI (kg/m2) | 24.1 (14.9–47.7) | 23.8 (16.4–34.6) | 0.04 | 27.9 (20.9–47.7) | 26.3 (21.7–34.6) | 0.05 | 22.6 (14.9–37.2) | 23.5 (16.4–30.8) | 0.21 |